TBC1D21
geneOn this page
Also known as MGC34741MgcRabGAP
Summary
TBC1D21 (TBC1 domain family member 21, HGNC:28536) is a protein-coding gene on chromosome 15q24.1, encoding TBC1 domain family member 21 (Q8IYX1). Acts as a GTPase-activating protein for Rab family protein(s).
Enables GTPase activator activity and small GTPase binding activity. Predicted to be involved in plasma membrane to endosome transport; sperm axoneme assembly; and sperm mitochondrial sheath assembly. Located in extracellular exosome.
Source: NCBI Gene 161514 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_153356
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28536 |
| Approved symbol | TBC1D21 |
| Name | TBC1 domain family member 21 |
| Location | 15q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC34741, MgcRabGAP |
| Ensembl gene | ENSG00000167139 |
| Ensembl biotype | protein_coding |
| OMIM | 620387 |
| Entrez | 161514 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000300504, ENST00000535547, ENST00000562056
RefSeq mRNA: 2 — MANE Select: NM_153356
NM_001286434, NM_153356
CCDS: CCDS10252, CCDS66822
Canonical transcript exons
ENST00000300504 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001110256 | 73886078 | 73886174 |
| ENSE00001110257 | 73884151 | 73884245 |
| ENSE00001110259 | 73885003 | 73885103 |
| ENSE00001110264 | 73884781 | 73884891 |
| ENSE00001163163 | 73887620 | 73887736 |
| ENSE00001163169 | 73886512 | 73886612 |
| ENSE00001277253 | 73888430 | 73888513 |
| ENSE00001277293 | 73881644 | 73881747 |
| ENSE00001277297 | 73881399 | 73881506 |
| ENSE00001277308 | 73889069 | 73889214 |
| ENSE00001277317 | 73873564 | 73873769 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 91.51.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0673 / max 66.7606, expressed in 3 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147616 | 0.0240 | 3 |
| 147619 | 0.0217 | 3 |
| 147617 | 0.0172 | 3 |
| 147618 | 0.0044 | 3 |
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 91.51 | gold quality |
| left testis | UBERON:0004533 | 91.17 | gold quality |
| testis | UBERON:0000473 | 88.08 | gold quality |
| sperm | CL:0000019 | 82.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.10 | gold quality |
| tibialis anterior | UBERON:0001385 | 71.74 | silver quality |
| ileal mucosa | UBERON:0000331 | 66.34 | silver quality |
| adult organism | UBERON:0007023 | 62.50 | gold quality |
| pancreatic ductal cell | CL:0002079 | 62.24 | silver quality |
| deltoid | UBERON:0001476 | 58.65 | gold quality |
| myocardium | UBERON:0002349 | 55.39 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.92 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 54.41 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| buccal mucosa cell | CL:0002336 | 53.38 | gold quality |
| cerebellar vermis | UBERON:0004720 | 51.91 | gold quality |
| upper leg skin | UBERON:0004262 | 51.76 | silver quality |
| quadriceps femoris | UBERON:0001377 | 49.63 | gold quality |
| skin of hip | UBERON:0001554 | 48.04 | silver quality |
| vastus lateralis | UBERON:0001379 | 46.64 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 44.51 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| thymus | UBERON:0002370 | 43.47 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| oocyte | CL:0000023 | 43.08 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.86 | gold quality |
| gingival epithelium | UBERON:0001949 | 42.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting TBC1D21, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-1301-3P | 98.64 | 68.27 | 1071 |
| HSA-MIR-5047 | 98.64 | 68.62 | 1035 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
Literature-anchored findings (GeneRIF, showing 3)
- MgcRabGAP is involved in acrosome/acroplaxome formation and cytoskeletal reorganization via Rab activity during mammalian spermiogenesis (PMID:21128978)
- Data indicate that single-nucleotide polymorphisms (SNPs) distributing in not only lysyl oxidase-like 1 gene (LOXL1) but also TBC1 domain family member 21 protein (TBC1D21) and promyelocytic leukemia protein (PML). (PMID:24938310)
- Deficiency of the Tbc1d21 gene causes male infertility with morphological abnormalities of the sperm mitochondria and flagellum in mice. (PMID:32976492)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tbc1d21 | ENSMUSG00000036244 |
| rattus_norvegicus | Tbc1d21 | ENSRNOG00000008737 |
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512), TBC1D3 (ENSG00000274611)
Protein
Protein identifiers
TBC1 domain family member 21 — Q8IYX1 (reviewed: Q8IYX1)
Alternative names: Male germ cell Rab GTPase-activating protein
All UniProt accessions (2): Q8IYX1, H3BTA9
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a GTPase-activating protein for Rab family protein(s). Essential for the establishment of male fertility, and is required for both the production of normal sperm number and sperm function. Plays an important role in the formation of intact mitochondria, outer dense fibers and axoneme within the sperm tail. Essential for sperm mitochondrial sheath formation and for the interactions of ARMC12 with VDAC2 and VDAC3. May be involved in acrosome formation and cytoskeletal reorganization during spermiogenesis, possibly by regulating RAB3A activity.
Subunit / interactions. Interacts with ACTB. Interacts with ARMC12, TOMM20, DNAH7 and RAP1A. Interacts with RAB10.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Cytoplasm. Cytoskeleton.
Tissue specificity. Expressed in round and elongated spermatids (at protein level). Expressed specifically in adult testis and very weakly in fetal brain.
Domain organisation. The arginine and glutamine fingers are critical for the GTPase-activating mechanism, they pull out Rab’s ‘switch 2’ glutamine and insert in Rab’s active site.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IYX1-1 | 1 | yes |
| Q8IYX1-2 | 2 |
RefSeq proteins (2): NP_001273363, NP_699187* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
Pfam: PF00566
UniProt features (6 total): site 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYX1-F1 | 93.19 | 0.84 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 124 (arginine finger); 163 (glutamine finger)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_MALE_GAMETE_GENERATION, GOMF_GTPASE_BINDING, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOMF_ACTIN_BINDING, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_REGULATION_OF_CILIUM_ASSEMBLY
GO Biological Process (6): spermatogenesis (GO:0007283), sperm axoneme assembly (GO:0007288), flagellated sperm motility (GO:0030317), plasma membrane to endosome transport (GO:0048227), sperm mitochondrial sheath assembly (GO:0120317), cell differentiation (GO:0030154)
GO Molecular Function (4): actin binding (GO:0003779), GTPase activator activity (GO:0005096), small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (6): acrosomal vesicle (GO:0001669), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410), extracellular exosome (GO:0070062), sperm midpiece (GO:0097225), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 2 |
| sperm flagellum assembly | 2 |
| cellular anatomical structure | 2 |
| male gamete generation | 1 |
| axoneme assembly | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| vesicle-mediated transport | 1 |
| cellular component assembly | 1 |
| cellular developmental process | 1 |
| cytoskeletal protein binding | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| GTPase binding | 1 |
| binding | 1 |
| secretory granule | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
| extracellular vesicle | 1 |
| sperm flagellum | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
434 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBC1D21 | TBC1D19 | Q8N5T2 | 665 |
| TBC1D21 | TBC1D22B | Q9NU19 | 646 |
| TBC1D21 | TBC1D13 | Q9NVG8 | 626 |
| TBC1D21 | ARMC12 | Q5T9G4 | 611 |
| TBC1D21 | TBC1D20 | Q96BZ9 | 594 |
| TBC1D21 | TBC1D10C | Q8IV04 | 589 |
| TBC1D21 | TBC1D1 | Q86TI0 | 566 |
| TBC1D21 | TBC1D10A | Q9BXI6 | 564 |
| TBC1D21 | TBC1D7 | Q9P0N9 | 557 |
| TBC1D21 | TBC1D22A | Q8WUA7 | 542 |
| TBC1D21 | TBC1D8B | Q0IIM8 | 540 |
| TBC1D21 | TBC1D8 | O95759 | 530 |
| TBC1D21 | TBC1D12 | O60347 | 526 |
| TBC1D21 | TBC1D2B | Q9UPU7 | 523 |
| TBC1D21 | TBC1D9B | Q66K14 | 519 |
IntAct
100 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TBC1D21 | KIF26A | psi-mi:“MI:0915”(physical association) | 0.600 |
| KIF26A | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.600 |
| TBC1D21 | SEPTIN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | EVI5L | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | TCF12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GFAP | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRT15 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | SNX7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | KRT35 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REL | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT38 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GTF2E1 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | RAB3IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| PMF1 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | RIBC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCN2 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GAS2 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM10 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | SAMD4A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D21 | CFAP53 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NR1D2 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDCD2 | TBC1D21 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (33): TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid), TBC1D21 (Two-hybrid)
ESM2 similar proteins: A1A5K6, A3KGB4, A6H8I2, A8E7G4, A8XSV3, B0R0W9, D3ZGS3, F1QRX7, F6UMY3, F8VPZ3, H2KZZ6, I2HAA0, O43048, O95759, P26448, P36618, Q01968, Q09445, Q0IIM8, Q0P5W1, Q19317, Q2KI13, Q3UYK3, Q55EP9, Q5E9C4, Q5SVR0, Q5ZLD2, Q68F70, Q6NTN5, Q6NU25, Q6NVF0, Q6P6R7, Q6ZT07, Q7T2D0, Q8BH88, Q8IYX1, Q8N3P4, Q8NFA0, Q8TC07, Q8TEU7
Diamond homologs: Q8IYX1, Q9D9D3, Q94BY9
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 28 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 5 | 23.1× | 1e-04 |
| Keratinization | 5 | 14.7× | 6e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| morphogenesis of an epithelium | 5 | 66.1× | 8e-07 |
| intermediate filament organization | 6 | 55.6× | 1e-07 |
| epithelial cell differentiation | 5 | 33.8× | 2e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2013 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:73881745:G:GT | donor_gain | 1.0000 |
| 15:73884147:ACAGG:A | acceptor_loss | 1.0000 |
| 15:73884148:CAGG:C | acceptor_loss | 1.0000 |
| 15:73884149:A:AG | acceptor_gain | 1.0000 |
| 15:73884150:G:GA | acceptor_loss | 1.0000 |
| 15:73884150:G:GG | acceptor_gain | 1.0000 |
| 15:73884150:GGAA:G | acceptor_gain | 1.0000 |
| 15:73884241:CATTG:C | donor_gain | 1.0000 |
| 15:73884242:ATTG:A | donor_gain | 1.0000 |
| 15:73884243:TTG:T | donor_gain | 1.0000 |
| 15:73884244:TG:T | donor_gain | 1.0000 |
| 15:73884245:GG:G | donor_gain | 1.0000 |
| 15:73884245:GGT:G | donor_loss | 1.0000 |
| 15:73884246:G:GG | donor_gain | 1.0000 |
| 15:73884767:T:A | acceptor_gain | 1.0000 |
| 15:73884774:A:AG | acceptor_gain | 1.0000 |
| 15:73884775:A:G | acceptor_gain | 1.0000 |
| 15:73884777:CTA:C | acceptor_loss | 1.0000 |
| 15:73884778:TAGC:T | acceptor_loss | 1.0000 |
| 15:73884779:A:AG | acceptor_gain | 1.0000 |
| 15:73884779:AGCA:A | acceptor_loss | 1.0000 |
| 15:73884780:G:GG | acceptor_gain | 1.0000 |
| 15:73884780:GC:G | acceptor_gain | 1.0000 |
| 15:73884780:GCA:G | acceptor_gain | 1.0000 |
| 15:73884780:GCAC:G | acceptor_gain | 1.0000 |
| 15:73884888:GCAG:G | donor_gain | 1.0000 |
| 15:73884889:CAGGT:C | donor_loss | 1.0000 |
| 15:73884890:AGG:A | donor_loss | 1.0000 |
| 15:73884891:GGTG:G | donor_loss | 1.0000 |
| 15:73884893:T:A | donor_loss | 1.0000 |
AlphaMissense
2266 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:73881432:T:A | W32R | 0.991 |
| 15:73881432:T:C | W32R | 0.991 |
| 15:73881674:T:A | W67R | 0.991 |
| 15:73881674:T:C | W67R | 0.991 |
| 15:73886611:A:T | E259V | 0.986 |
| 15:73881434:G:C | W32C | 0.984 |
| 15:73881434:G:T | W32C | 0.984 |
| 15:73881664:G:C | R63S | 0.984 |
| 15:73881664:G:T | R63S | 0.984 |
| 15:73886550:T:A | W239R | 0.984 |
| 15:73886550:T:C | W239R | 0.984 |
| 15:73886607:T:A | W258R | 0.982 |
| 15:73886607:T:C | W258R | 0.982 |
| 15:73881723:G:C | R83P | 0.981 |
| 15:73888467:T:C | L311P | 0.981 |
| 15:73887666:C:A | A275D | 0.978 |
| 15:73886554:T:C | F240S | 0.977 |
| 15:73887678:T:C | L279P | 0.977 |
| 15:73886127:T:C | L210P | 0.976 |
| 15:73886605:T:C | L257P | 0.976 |
| 15:73886610:G:A | E259K | 0.975 |
| 15:73886565:T:C | F244L | 0.974 |
| 15:73886567:C:A | F244L | 0.974 |
| 15:73886567:C:G | F244L | 0.974 |
| 15:73888479:C:A | A315D | 0.971 |
| 15:73881663:G:C | R63T | 0.970 |
| 15:73881676:G:C | W67C | 0.970 |
| 15:73881676:G:T | W67C | 0.970 |
| 15:73886553:T:C | F240L | 0.969 |
| 15:73886555:C:A | F240L | 0.969 |
dbSNP variants (sampled 300 via entrez): RS1000055982 (15:73903017 T>C), RS1000062051 (15:73897244 T>C), RS1000076726 (15:73888364 T>A), RS1000106598 (15:73902759 G>A), RS1000274750 (15:73909484 A>G), RS1000423060 (15:73907649 C>T), RS1000451399 (15:73895934 A>G), RS1000509443 (15:73892708 T>C), RS1000616721 (15:73898315 G>A), RS1000687412 (15:73886932 C>A,T), RS1000688563 (15:73896946 G>A), RS1000715823 (15:73872547 G>A,C,T), RS1000754626 (15:73885722 G>T), RS1000814241 (15:73880875 C>G,T), RS1000850178 (15:73890016 TACAC>T,TAC,TACACAC)
Disease associations
OMIM: gene MIM:620387 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002486_1 | Exfoliation glaucoma or exfoliation syndrome | 2.000000e-16 |
| GCST002726_4 | Glucose homeostasis traits | 7.000000e-08 |
| GCST006947_18 | Feeling fed-up | 8.000000e-09 |
| GCST008059_242 | Estimated glomerular filtration rate | 6.000000e-10 |
| GCST010108_17 | Coffee consumption (cups per day) | 3.000000e-08 |
| GCST011741_43 | LDL cholesterol levels in HIV infection | 1.000000e-07 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004471 | insulin sensitivity measurement |
| EFO:0009588 | feeling “fed-up” measurement |
| EFO:0006782 | cups of coffee per day measurement |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Silicon Dioxide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): exfoliation syndrome